|
KDM1A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.748200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.817400E-01 |
| Normal-vs-Stage2 |
8.586400E-01 |
| Normal-vs-Stage3 |
1.866960E-01 |
| Normal-vs-Stage4 |
3.510400E-02 |
| Stage1-vs-Stage2 |
7.590600E-01 |
| Stage1-vs-Stage3 |
3.708800E-01 |
| Stage1-vs-Stage4 |
6.845900E-02 |
| Stage2-vs-Stage3 |
4.013400E-01 |
| Stage2-vs-Stage4 |
1.500170E-01 |
| Stage3-vs-Stage4 |
4.048600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.374200E-01 |
| Normal-vs-AfricanAmerican |
2.065000E-01 |
| Normal-vs-Asian |
4.211400E-01 |
| Caucasian-vs-AfricanAmerican |
1.016230E-01 |
| Caucasian-vs-Asian |
8.236000E-01 |
| AfricanAmerican-vs-Asian |
1.037040E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.268200E-01 |
| Normal-vs-Female |
1.758410E-01 |
| Male-vs-Female |
2.355000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.975400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.197000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.514220E-01 |
| Normal-vs-Age(81-100Yrs) |
6.261200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.632800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.776050E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.118000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.193000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.287400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.956800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.000100E-03 |
| Classical-VS-Follicular |
1.399090E-03 |
| Classical-VS-Other |
6.830400E-01 |
| Classical-VS-Normal |
7.602400E-01 |
| Tall-VS-Follicular |
6.642600E-01 |
| Tall-VS-Other |
4.740600E-01 |
| Tall-VS-Normal |
6.623200E-03 |
| Follicular-VS-Other |
5.030000E-01 |
| Follicular-VS-Normal |
1.530280E-02 |
| Other-VS-Normal |
8.320200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.610800E-01 |
| Normal-vs-N1 |
3.583200E-03 |
| N0-vs-N1 |
1.515750E-02 |
|
|
